Shayne & Jacobs LLC’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$228K Buy
+907
New +$195K 0.07% 97
2026
Q1
Sell
-907
Closed -$207K 95
2025
Q4
$207K Hold
907
0.06% 94
2025
Q3
$210K Buy
+907
New +$185K 0.07% 95
2015
Q3
Sell
-3,163
Closed -$212K 19
2015
Q2
$212K Sell
3,163
-305
-9% -$19.9K 0.18% 20
2015
Q1
$203K Hold
3,468
0.16% 23
2014
Q4
$227K Sell
3,468
-293
-8% -$18.5K 0.17% 20
2014
Q3
$218K Hold
3,761
0.17% 19
2014
Q2
$212K Sell
3,761
-555
-13% -$29.1K 0.17% 19
2014
Q1
$222K Hold
4,316
0.18% 21
2013
Q4
$228K Buy
+4,316
New +$212K 0.19% 21

Other funds holding ABBV

Shayne & Jacobs LLC's ABBV Position: Q2 2026 in Review

Shayne & Jacobs LLC opened a new position in AbbVie (ABBV) in Q2 2026: 907 shares worth $228K. The stake represents 0.07% of the portfolio and ranks #97 among its holdings. This is a return to the name: Shayne & Jacobs LLC previously reported a position in ABBV as recently as Q4 2025.

Shayne & Jacobs LLC first reported a position in ABBV in Q4 2013 and has held it in 10 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Shayne & Jacobs LLC held 907 shares of AbbVie worth $228K as of Q2 2026.
  • AbbVie was a new Shayne & Jacobs LLC position in Q2 2026.
  • AbbVie made up 0.07% of Shayne & Jacobs LLC's portfolio in Q2 2026, its #97 holding.
  • Shayne & Jacobs LLC first reported a position in AbbVie in Q4 2013 and has held it in 10 quarters since.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Shayne & Jacobs LLC's 13F filing for Q2 2026, filed 7 Jul 2026.